Precision medicine: an opportunity for a paradigm shift in veterinary medicine.
作者信息
Lloyd K C Kent, Khanna Chand, Hendricks William, Trent Jeffrey, Kotlikoff Michael
出版信息
J Am Vet Med Assoc. 2016 Jan 1;248(1):45-8. doi: 10.2460/javma.248.1.45.
Abstract
摘要
相似文献
1
Precision medicine: an opportunity for a paradigm shift in veterinary medicine.
J Am Vet Med Assoc. 2016 Jan 1;248(1):45-8. doi: 10.2460/javma.248.1.45.
2
[Gene technology renews diagnosis of animal diseases].
Tijdschr Diergeneeskd. 2013 Feb 1;138(2):110-2.
3
Wildlife diseases and population medicine.
J Am Vet Med Assoc. 1992 Mar 1;200(5):648-52.
4
DNA sequencing 'shaping the future of veterinary science'.
Vet Rec. 2012 Jul 21;171(3):61.
5
[Third ONCOlogic Meeting].
Tijdschr Diergeneeskd. 2008 Jul 1;133(13):578-80.
6
[Mandatory notification and onset of disease].
Tijdschr Diergeneeskd. 2012 Jul;137(7):468-9, 471.
7
Veterinary medicine, global health.
J Am Vet Med Assoc. 2007 Dec 15;231(12):1806-8. doi: 10.2460/javma.231.12.1806.
8
The treatment of inherited conditions in animals.
Vet J. 1998 Jul;156(1):3-4. doi: 10.1016/s1090-0233(98)80053-1.
9
BSAVA awards, 2002.
J Small Anim Pract. 2002 Jun;43(6):279-80.
10
Bona diagnosis, bona curatio!
Prev Vet Med. 2009 Nov 15;92(3):177-8. doi: 10.1016/j.prevetmed.2009.08.013. Epub 2009 Sep 23.
引用本文的文献
1
Towards precision pain management in veterinary practise: opportunities and barriers.
Front Vet Sci. 2025 Aug 15;12:1658765. doi: 10.3389/fvets.2025.1658765. eCollection 2025.
2
Recent Issues in the Development and Application of Targeted Therapies with Respect to Individual Animal Variability.
Animals (Basel). 2025 Feb 6;15(3):444. doi: 10.3390/ani15030444.
3
The MARS PETCARE BIOBANK protocol: establishing a longitudinal study of health and disease in dogs and cats.
BMC Vet Res. 2023 Aug 17;19(1):125. doi: 10.1186/s12917-023-03691-4.
4
Artificial Intelligence and Precision Medicine: A New Frontier for the Treatment of Brain Tumors.
Life (Basel). 2022 Dec 22;13(1):24. doi: 10.3390/life13010024.
5
One Digital Health Intervention for Monitoring Human and Animal Welfare in Smart Cities: Viewpoint and Use Case.
JMIR Med Inform. 2023 May 19;11:e43871. doi: 10.2196/43871.
6
Banking on the Last Gift: Cornell's Signature Program of Postmortem Tissue Procurement.
Biopreserv Biobank. 2023 Feb;21(1):46-55. doi: 10.1089/bio.2021.0103. Epub 2022 Aug 5.
7
Genomic Medicine in Periodontal Disease: Old Issue, New Insights.
J Vet Dent. 2022 Dec;39(4):314-322. doi: 10.1177/08987564221109102. Epub 2022 Jun 28.
8
Constructing and analysing dynamic models with modelbase v1.2.3: a software update.
BMC Bioinformatics. 2021 Apr 20;22(1):203. doi: 10.1186/s12859-021-04122-7.
本文引用的文献
1
Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach.
Cancer Genet. 2015 Sep;208(9):441-7. doi: 10.1016/j.cancergen.2015.05.030. Epub 2015 May 29.
2
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team.
Mol Cancer Ther. 2015 Aug;14(8):1962-71. doi: 10.1158/1535-7163.MCT-15-0153. Epub 2015 Jun 10.
3
Toward precision medicine in glioblastoma: the promise and the challenges.
Neuro Oncol. 2015 Aug;17(8):1051-63. doi: 10.1093/neuonc/nov031. Epub 2015 May 1.
4
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.
Cancer Med. 2015 Jun;4(6):871-86. doi: 10.1002/cam4.436. Epub 2015 Feb 26.
5
A new initiative on precision medicine.
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
6
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.
J Natl Compr Canc Netw. 2014 Sep;12(9):1326-38. doi: 10.6004/jnccn.2014.0127.
7
Molecular analysis for therapy choice: NCI MATCH.
Semin Oncol. 2014 Jun;41(3):297-9. doi: 10.1053/j.seminoncol.2014.05.002. Epub 2014 May 22.
8
Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials.
PLoS One. 2014 Mar 17;9(3):e90028. doi: 10.1371/journal.pone.0090028. eCollection 2014.
9
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
PLoS Genet. 2014 Feb 13;10(2):e1004135. doi: 10.1371/journal.pgen.1004135. eCollection 2014 Feb.
10
A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases.
Hum Mutat. 2013 Dec;34(12):1721-6. doi: 10.1002/humu.22450. Epub 2013 Oct 18.
Zotero 插件